Skip to main content

Advertisement

SpringerLink
Log in

Is There a Correlation Between Breast Cancer Molecular Subtype Using Receptors as Surrogates and Mammographic Appearance?

  • Breast Oncology
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

The identification of distinct molecular subtypes has changed breast cancer management. The correlation between mammographic appearance and molecular subtype for invasive breast cancer has not been extensively studied.

Methods

A retrospective review of our prospectively collected database was performed to evaluate the mammographic appearance and molecular subtypes of all cases of invasive breast cancers diagnosed between 2003 and 2010.

Results

There were 985 cases of invasive breast cancer with complete data on receptor status and mammographic appearance. The most common mammographic finding was a mass (61 %), and the most common molecular subtype was ER/PR positive, HER2 negative (71 %). On univariate analysis, race, stage, and histology were all significantly associated with molecular subtype. On multivariate analysis, the luminal molecular type was associated with architectural distortion [odds ratio (OR) 4.3, 95 % CI 1.3–14.1]; HER2 positive cancers, either with or without ER/PR expression, were more likely to be associated with mammographic calcifications (OR 2.8 and 3.1, respectively; 95 % CI 1.7–4.8 and 1.7–5.5); and triple negative cancers were most likely to be associated with a mammographic mass (OR 2.5; 95 % CI 1.4–4.4).

Conclusions

We observed several characteristic associations between molecular subtype and mammographic appearance. Improved understanding of these associations may help guide clinical decision making and provide information about underlying tumor biology.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Jiang L, Ma T, Moran MS, Kong X, Li X, Haffty BG, et al. Mammographic features are associated with clinicopathological characteristics in invasive breast cancer. Anticancer Res. 2011;31:312327–34.

    Google Scholar 

  2. Breyer JP, Sanders ME, Airey DC, Cai Q, Yaspan BL, Schuyler PA, et al. Heritable variation of ERBB2 and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2009;18:1252–8.

    Article  CAS  PubMed  Google Scholar 

  3. Gonzalez-Angulo AM, Litton JK, Broglio KR, Meric-Bernstam F, Rakkhit R, Cardoso F, et al. High risk of recurrence for patients with breast cancer who have human epidermal growth factor receptor 2-positive, node-negative tumors 1 cm or smaller. J Clin Oncol. 2009;27:5700–6.

    Article  PubMed  Google Scholar 

  4. Heuser LS, Spratt JS, Kuhns JG, Chang AF, Polk HC Jr, Buchanan JB. The association of pathologic and mammographic characteristics of primary human breast cancers with “slow” and “fast” growth rates and with axillary lymph node metastases. Cancer. 1984;53:96–8.

    Article  CAS  PubMed  Google Scholar 

  5. Wang X, Chao L, Chen L, Tian B, Ma G, Zang Y, et al. Correlation of mammographic calcifications with Her-2/neu overexpression in primary breast carcinomas. J Digit Imaging. 2008;21:170–6.

    Article  CAS  PubMed  Google Scholar 

  6. Ferranti C, Coopmans de Yoldi G, Biganzoli E, Bergonzi S, Mariani L, Scaperrotta G, et al. Relationships between age, mammographic features and pathological tumour characteristics in non-palpable breast cancer. Br J Radiol. 2000;73:698–705.

    CAS  PubMed  Google Scholar 

  7. Evans AJ, Pinder SE, Ellis IO, Sibbering DM, Elston CW, Poller DN, et al. Correlations between the mammographic features of ductal carcinoma in situ (DCIS) and C-erbB-2 oncogene expression. Nottingham Breast Team. Clin Radiol. 1994;49:559–62.

    Article  CAS  PubMed  Google Scholar 

  8. Wang Y, Ikeda DM, Narasimhan B, Longacre TA, Bleicher RJ, Pal S, et al. Estrogen receptor-negative invasive breast cancer: imaging features of tumors with and without human epidermal growth factor receptor type 2 overexpression. Radiology. 2008;246:367–75.

    Article  PubMed  Google Scholar 

  9. Kim SH, Seo BK, Lee J, Kim SJ, Cho KR, Lee KY, et al. Correlation of ultrasound findings with histology, tumor grade, and biological markers in breast cancer. Acta Oncol. 2008;47:1531–8.

    Article  CAS  PubMed  Google Scholar 

  10. Foulkes WD, Stefansson IM, Chappuis PO, Bégin LR, Goffin JR, Wong N, et al. Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer. J Natl Cancer Inst. 2003;95:1482–5.

    Article  CAS  PubMed  Google Scholar 

  11. Nofech-Mozes S, Trudeau M, Kahn HK, Dent R, Rawlinson E, Sun P, et al. Patterns of recurrence in the basal and non-basal subtypes of triple-negative breast cancers. Breast Cancer Res Treat. 2009;118:131–7.

    Article  PubMed  Google Scholar 

  12. Rakha EA, Reis-Filho JS, Ellis IO. Basal-like breast cancer: a critical review. J Clin Oncol. 2008;26:2568–81.

    Article  PubMed  Google Scholar 

  13. Haffty BG, Yang Q, Reiss M, Kearney T, Higgins SA, Weidhaas J, et al. Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer. J Clin Oncol. 2006;24:5652–7.

    Article  PubMed  Google Scholar 

  14. Ko ES, Lee BH, Kim HA, Noh WC, Kim MS, Lee SA. Triple-negative breast cancer: correlation between imaging and pathological findings. Eur Radiol. 2010;20:1111–7.

    Article  PubMed  Google Scholar 

Download references

Disclosure

None.

Author information

Authors and Affiliations

  1. Department of Surgery, The Breast Center—Smilow Cancer Hospital at Yale-New Haven, Yale University School of Medicine, New Haven, CT, USA

    Brigid K. Killelea MD, MPH, Anees B. Chagpar MD, MSc, MPH, MA, Jennifer Bishop MD, Nina R. Horowitz MD, Carla Christy MD, Theodore Tsangaris MD, Madhavi Raghu MD & Donald R. Lannin MD

Authors
  1. Brigid K. Killelea MD, MPH
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anees B. Chagpar MD, MSc, MPH, MA
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jennifer Bishop MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Nina R. Horowitz MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Carla Christy MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Theodore Tsangaris MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Madhavi Raghu MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Donald R. Lannin MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Brigid K. Killelea MD, MPH.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Killelea, B.K., Chagpar, A.B., Bishop, J. et al. Is There a Correlation Between Breast Cancer Molecular Subtype Using Receptors as Surrogates and Mammographic Appearance?. Ann Surg Oncol 20, 3247–3253 (2013). https://doi.org/10.1245/s10434-013-3155-7

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-013-3155-7

Keywords

Search

Navigation